Increased expression of protease-activated receptors 2 indicates poor prognosis in HBV related hepatocellular carcinoma
Abstract Objective To investigate the potential role of protease-activated receptor 2 (PAR2) in the prognosis of hepatocellular carcinoma (HCC). Methods A total of 202 HCC patients who underwent liver resections were included. Tissue microarray was established with specimens of both HCC and paired a...
Main Authors: | Peng Chen, Na Yang, Li Xu, Fangfang Zhao, Min Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-11-01
|
Series: | Infectious Agents and Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13027-019-0256-3 |
Similar Items
-
Mitofusin-2 acts as biomarker for predicting poor prognosis in hepatitis B virus related hepatocellular carcinoma
by: Xiumei Wang, et al.
Published: (2018-11-01) -
CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC)
by: Yunhong Tian, et al.
Published: (2018-11-01) -
Decrease of RBM4 indicates poor prognosis in patients with hepatocellular carcinoma after hepatectomy
by: Chen J, et al.
Published: (2017-01-01) -
AGLR is a novel index for the prognosis of hepatocellular carcinoma patients: a retrospective study
by: Yan Liao, et al.
Published: (2021-02-01) -
Overexpression of LBH is associated with poor prognosis in human hepatocellular carcinoma
by: Chen JW, et al.
Published: (2018-01-01)